AIRLINK 69.92 Increased By ▲ 4.72 (7.24%)
BOP 5.46 Decreased By ▼ -0.11 (-1.97%)
CNERGY 4.50 Decreased By ▼ -0.06 (-1.32%)
DFML 25.71 Increased By ▲ 1.19 (4.85%)
DGKC 69.85 Decreased By ▼ -0.11 (-0.16%)
FCCL 20.02 Decreased By ▼ -0.28 (-1.38%)
FFBL 30.69 Increased By ▲ 1.58 (5.43%)
FFL 9.75 Decreased By ▼ -0.08 (-0.81%)
GGL 10.12 Increased By ▲ 0.11 (1.1%)
HBL 114.90 Increased By ▲ 0.65 (0.57%)
HUBC 132.10 Increased By ▲ 3.00 (2.32%)
HUMNL 6.73 Increased By ▲ 0.02 (0.3%)
KEL 4.44 No Change ▼ 0.00 (0%)
KOSM 4.93 Increased By ▲ 0.04 (0.82%)
MLCF 36.45 Decreased By ▼ -0.55 (-1.49%)
OGDC 133.90 Increased By ▲ 1.60 (1.21%)
PAEL 22.50 Decreased By ▼ -0.04 (-0.18%)
PIAA 25.39 Decreased By ▼ -0.50 (-1.93%)
PIBTL 6.61 Increased By ▲ 0.01 (0.15%)
PPL 113.20 Increased By ▲ 0.35 (0.31%)
PRL 30.12 Increased By ▲ 0.71 (2.41%)
PTC 14.70 Decreased By ▼ -0.54 (-3.54%)
SEARL 57.55 Increased By ▲ 0.52 (0.91%)
SNGP 66.60 Increased By ▲ 0.15 (0.23%)
SSGC 10.99 Increased By ▲ 0.01 (0.09%)
TELE 8.77 Decreased By ▼ -0.03 (-0.34%)
TPLP 11.51 Decreased By ▼ -0.19 (-1.62%)
TRG 68.61 Decreased By ▼ -0.01 (-0.01%)
UNITY 23.47 Increased By ▲ 0.07 (0.3%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 7,399 Increased By 104.2 (1.43%)
BR30 24,136 Increased By 282 (1.18%)
KSE100 70,910 Increased By 619.8 (0.88%)
KSE30 23,377 Increased By 205.6 (0.89%)
Technology

'Zantac' may cause cancer, being pulled from shelves in USA but not in Pakistan

Food and Drug Administration in US had issued warning of drug containing carcinogen ingredients. Canada, Franc
Published October 2, 2019
  • Food and Drug Administration in US had issued warning of drug containing carcinogen ingredients.
  • Canada, France and other countries have already suspended selling of drug.

Pharmacy chains in the United States have suspended the sale of heartburn medication Zantac after the Food and Drug Administration (FDA) issued a warning that the drug contained potentially cancer-causing ingredients.

The pharmacy chains Walgreens, Rite Aid and CVS have announced that they are no longer selling Zantac and other ranitidine products. Rite Aid is in the process of removing Zantac and generic versions sold under the Rite Aid name from its shelves, a Rite Aid spokesman told New York Times.

CVS has already announced that it has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice. "Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time," the CVS said.

Since the alert by FDA, Canada, France and other countries have removed the drugs from pharmacy shelves. Bangladesh also issued a temporary ban on the import, production and sale of ranitidine.

Drap engages international bodies for further probe after medicine recall over cancer fears

Ranitidine is a medication that works to lower the acid created in the stomach. The drug is also prescribed to prevent ulcers of the stomach and intestines as well as gastroesophageal reflux disease.

Last month, the FDA issued a statement alerting patients and health care professionals of N-nitrosodimethylamine (NDMA) found in samples of ranitidine. "The U.S. FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels," the statement said.

NDMA is classified as a probable human carcinogen which is a substance that could cause cancer on the basis of animal studies. It is known environmental contaminant and found in water and foods, including meats, dairy products and vegetables.

Copyright Business Recorder, 2019

Comments

Comments are closed.